BioSight
Companies
Elanco Animal Health Inc logo

ELAN

NYSEINDIANAPOLIS, IN
Elanco Animal Health Inc

Elanco develops and sells animal health products for farm animals and other veterinary applications. The company operates through product sales across multiple therapeutic areas, competing in a landscape that includes both branded and generic alternatives while navigating regulatory restrictions on antibiotic use in livestock. Elanco pursues growth through research and development efforts, product launches, and acquisitions, though success depends on regulatory approval, manufacturing capacity, and integration of acquired businesses.

$22.37+135.97%1Y
ELAN · daily close · illustrative · 0 catalysts marked
$7.73$13$18$23$29Apr '25Aug '25Dec '25Apr '26
1Y high$26.841Y low$9.47range$17.37(183%)past catalysts

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar